Otros idiomas Mankind Pharma Limited

Acciones

MANKIND

INE634S01028

Mercado cerrado - NSE India S.E. Otros sitios de cotización 13:43:53 31/05/2024			Varia. Cinco días.	Varia. 1 de enero.
2.140 ^INR	+2,18 %		+3,73 %	+7,93 %

30/05	Advent International recibe entre 6 y 7 ofertas por Bharat Serums	CI
16/05	Transcript : Mankind Pharma Limited, Q4 2024 Earnings Call, May 16, 2024

Otros idiomas

Desbloquee todas las noticias sobre todas las empresas: ¡No vuelvas a perderse una oportunidad de inversión rentable!

Inscripción 100% Gratuita

Advent International Receives 6-7 Bids for Bharat Serums	30/05
Transcript : Mankind Pharma Limited, Q4 2024 Earnings Call, May 16, 2024	16/05
Mankind Pharma's Consolidated Profit Jumps in Fiscal Q4	16/05
India's Mankind Pharma's Q4 profit jumps on strength in chronic drugs segment	15/05
Mankind Pharma Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2024	15/05
India's weight in key MSCI equity index hits another high, to boost inflows	15/05
Mankind Pharma Reportedly in Fray to Acquire Advent's Stake in Bharat Serums	14/05
KKR, Novo Nordisk, Others Reportedly Bid for Healthium Buy	03/05
CARE Gives AA+ Rating to Mankind Pharma's Long-term Bank Financing; Outlook Stable	26/04
Mankind Pharma to Sell its Over the Counter Business on Slump Sale Basis	04/04
Mankind Pharma to Sell OTC Business to Wholly-Owned Subsidiary	03/04
Mankind Pharma to Form New Subsidiary for Consumer Healthcare Products	02/04
Mankind Pharma Limited Announces Incorporation of Wholly Owned Subsidiary Mankind Consumer Products Private Limited	02/04
Mankind Reportedly Joins Race for Healthium Medtech	29/03
AstraZeneca, Mankind Pharma Tie Up for Exclusive Distribution of Asthma Drug Symbicort in India	11/03
Astrazeneca Pharma India Ltd and Mankind Pharma Partner to Accelerate Access to Asthma Medicine for Patients in India	11/03
India's Jubilant Pharmova posts quarterly profit	02/02
Transcript : Mankind Pharma Limited, Q3 2024 Earnings Call, Feb 02, 2024	02/02
Mankind Pharma Posts Gains in Fiscal Q3 Consolidated Net Profit; Shares Rise 3%	01/02
India's Mankind Pharma beats Q3 profit estimates on strong demand	31/01

No hay resultados para esta búsqueda

Todas Recomendaciones analistas Eventos destacados Insiders Transcripts Comunicados Publs. oficiales Otros idiomas Ideas de trading Artículos de MarketScreener Estrategias MarketScreener

Otros idiomas Mankind Pharma Limited

Acciones

MANKIND

INE634S01028

Otros idiomas

Filtros